Is IONQ The Next NVIDIA?
Quantum computing startup IonQ (NYSE:IONQ) has seen its stock skyrocket…
Sell
11
CLF Quote, Financials, Valuation and Earnings
Last price:
$7.19
Seasonality move
:
3.37%
Day range:
$5.63 - $5.86
52-week range:
$5.63 - $17.41
Dividend yield:
0%
P/E ratio:
175.97x
P/S ratio:
0.15x
P/B ratio:
0.46x
Volume:
47.8M
Avg. volume:
24.4M
1-year change:
-65.36%
Market cap:
$2.9B
Revenue:
$19.2B
EPS (TTM):
-$2.44
Analysts' Opinion
-
Consensus RatingCleveland-Cliffs has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 7 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $9.09, Cleveland-Cliffs has an estimated upside of 55.85% from its current price of $5.83.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $5.83.
Fair Value
-
According to the consensus of 10 analysts, Cleveland-Cliffs has 55.85% upside to fair value with a price target of $9.09 per share.
CLF vs. S&P 500
-
Over the past 5 trading days, Cleveland-Cliffs has underperformed the S&P 500 by -17.9% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Cleveland-Cliffs does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cleveland-Cliffs revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Cleveland-Cliffs reported revenues of $4.6B.
Earnings Growth
-
Cleveland-Cliffs earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Cleveland-Cliffs reported earnings per share of -$1.00.
Enterprise value:
10.7B
EV / Invested capital:
0.76x
Price / LTM sales:
0.15x
EV / EBIT:
24.80x
EV / Revenue:
0.57x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-10.12x
Price / Operating cash flow:
9.59x
Enterprise value / EBITDA:
30.27x
Gross Profit (TTM):
-$606M
Return On Assets:
-6.37%
Net Income Margin (TTM):
-6.35%
Return On Equity:
-16.75%
Return On Invested Capital:
-9.7%
Operating Margin:
-11.56%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $22.3B | $21.9B | $18.6B | $5.2B | $4.6B | |
| Gross Profit | $1.4B | $1.6B | -$606M | $285M | -$391M | |
| Operating Income | $847M | $975M | -$1.2B | $130M | -$535M | |
| EBITDA | $1.9B | $1.8B | -$63M | $233M | -$208M | |
| Diluted EPS | $0.90 | $0.74 | -$2.44 | -$0.14 | -$1.00 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $5.9B | $8.6B | $7.4B | $6.5B | $7B | |
| Total Assets | $17.2B | $19.8B | $18.7B | $17.2B | $20.8B | |
| Current Liabilities | $2.9B | $3.8B | $3.5B | $3.4B | $3.3B | |
| Total Liabilities | $14.5B | $13.2B | $10.9B | $9.8B | $14.4B | |
| Total Equity | $2.7B | $6.6B | $7.8B | $7.4B | $6.5B | |
| Total Debt | $5.7B | $5B | $4.6B | $3.7B | $7.6B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.9B | $2.4B | -$388M | $142M | -$351M | |
| Cash From Investing | -$886M | -$585M | -$3.2B | -$179M | -$145M | |
| Cash From Financing | -$941M | -$1.9B | $3.6B | -$131M | $499M | |
| Free Cash Flow | $956M | $1.8B | -$1.1B | -$40M | -$503M | |
CLF
Sector
Market Cap
$2.9B
$18.2M
Price % of 52-Week High
33.49%
64.4%
Dividend Yield
0%
0%
Shareholder Yield
-18.89%
0.87%
1-Year Price Total Return
-65.36%
-17.17%
Beta (5-Year)
1.849
0.758
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.49
200-day SMA
Sell
Level
$10.60
Bollinger Bands (100)
Sell
Level
7.49 - 10.57
Chaikin Money Flow
Sell
Level
-3.1M
20-day SMA
Sell
Level
$7.29
Relative Strength Index (RSI14)
Sell
Level
28.23
ADX Line
Sell
Level
18.57
Williams %R
Buy
Level
-91.4163
50-day SMA
Sell
Level
$7.73
MACD (12, 26)
Sell
Level
-0.32
25-day Aroon Oscillator
Sell
Level
-76
On Balance Volume
Sell
Level
-345.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.2947)
Sell
CA Score
(Annual)
Level (-0.7674)
Sell
Beneish M-Score
(Annual)
Level (5.7699)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.4585)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.
Stock Forecast FAQ
In the current month, CLF has received 2 Buy ratings 7 Hold ratings, and 1 Sell ratings. The CLF average analyst price target in the past 3 months is $9.09.
-
Where Will Cleveland-Cliffs Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cleveland-Cliffs share price will rise to $9.09 per share over the next 12 months.
-
What Do Analysts Say About Cleveland-Cliffs?
Analysts are divided on their view about Cleveland-Cliffs share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cleveland-Cliffs is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is Cleveland-Cliffs's Price Target?
The price target for Cleveland-Cliffs over the next 1-year time period is forecast to be $9.09 according to 10 Wall Street analysts, 2 of them rate the stock a Buy, 1 rates the stock a Sell, and 7 analysts rate the stock a Hold.
-
Is CLF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cleveland-Cliffs is a Hold. 7 of 10 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CLF?
You can purchase shares of Cleveland-Cliffs via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cleveland-Cliffs shares.
-
What Is The Cleveland-Cliffs Share Price Today?
Cleveland-Cliffs was last trading at $7.19 per share. This represents the most recent stock quote for Cleveland-Cliffs. Yesterday, Cleveland-Cliffs closed at $5.83 per share.
-
How To Buy Cleveland-Cliffs Stock Online?
In order to purchase Cleveland-Cliffs stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Best AI Index Fund to Buy
Over the last two years, companies with a focus on…
Where Will Salesforce Stock Be in 5 Years?
Salesforce (NYSE: CRM) just turned in a quarter that, on…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for Jun 2
Regeneron Pharmaceuticals [REGN] is up 0.05% over the past day.
Buy
55
RGC alert for Jun 2
Regencell Bioscience Holdings [RGC] is down 19.04% over the past day.
Sell
42
AMBA alert for Jun 2
Ambarella [AMBA] is up 0.93% over the past day.
